Stay updated on Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Only minor formatting and textual adjustments were observed; the core study information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T20:39:16.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.
    Difference
    3%
    Check dated 2025-10-06T04:49:02.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.1%
    Check dated 2025-09-29T02:54:28.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Updated version from v3.0.1 to v3.0.2; removed the 'Back to Top' element.
    Difference
    0.2%
    Check dated 2025-09-14T18:47:17.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T13:13:48.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as various new medical terms related to proteins and antibodies. Notably, rucaparib has been both added and removed, indicating a potential update in its relevance or classification.
    Difference
    2%
    Check dated 2025-08-31T10:10:25.000Z thumbnail image

Stay in the know with updates to Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.